Partial Epilepsy clinical trials
19 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
- A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- Study of Transcranial Direct Current Stimulation to Treat Epilepsy
- Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
- Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- Investigating Epilepsy: Screening and Evaluation
- Sleep Architecture & Cognition in Focal Epilepsy
- Breathing Rescue for SUDEP Prevention
- Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
- Spatial Scene Recognition Memory in Epilepsy Surgery
- An Open-label Study of XEN1101 in Epilepsy
- Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Partial Epilepsy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.